复旦张江(01349.HK)公布2020年度业绩 建议派发股息每股0.05元
格隆汇 3 月 25日丨复旦张江(01349.HK)发布截至2020年12月31日止年度的年度业绩公告,2020年度,集团实现收入约人民币8.338亿元;其中主营业务收入约达人民币8.325亿元(占营业收入的99.84%),同比下降19%。集团主要产品艾拉®(盐酸氨酮戊酸散,ALA)和里葆多®(盐酸多柔比星脂质体,Doxorubicin liposome)为集团营业收入做出很大贡献,分别占集团收入的36%和53%。集团2020年度的营业收入主要来自于医疗及诊断产品销售收入。2019年度的主要收入来源与本年基本一致。
报告期内因处于疫情管控期间,前往各地医院及附属科室就诊的患者数量及就诊频率明显低于正常水平。随着国内疫情基本得到控制,药品流通及医院患者就诊逐步恢复,集团各医药产品的出货量及药品终端使用量亦开始逐步恢复,但集团2020年度经营业绩仍受到较大影响。
2020年度,集团净利润约为人民币1.64亿元,同比减少约26%。2020年度,集团净利润率为20%,2019年同期为21%。2020净利润率较低主要因为集团由于新冠的影响销售收入下降,固定支出保持不变,研发投入增加,导致净利润率下降。2020年度,公司股东于合并财务报表中应占年度利润约为人民币1.65亿元,比2019年同期下降28%。建议派发股息每股人民币0.05元(含税),总计约人民币5215万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.